The aim of the COVID-19 Vaccine Safety Monitoring Plan is to strengthen the existing vaccine vigilance system for early detection and investigation of suspected side effects (also known as adverse events) following COVID-19 immunisation. This will enable the TGA to manage any emerging safety issues and help maintain public confidence in the immunisation program.

The key objectives of the COVID-19 Vaccine Safety Monitoring Plan are:

1. timely collection and management of reports of COVID-19 vaccine adverse events following immunisation
2. timely detection and investigation of COVID-19 vaccine safety signals
3. timely action to address any COVID-19 vaccine safety concerns
4. timely communications to inform the public of emerging COVID-19 vaccine safety information and to support public confidence in vaccines
5. close collaboration and coordination of effort with other vaccine safety stakeholder groups.